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1. Introduction 
The prognostic power of angiographic coronary anatomy has been definitively established 
since the CASS registry (1), where the 12-year survival rate of medically treated patients 
with no significant coronary lesions was 91%, compared with 74, 59 and 50% for patients 
with one, two and three vessel disease. Survival rate is known to further decrease in the 
presence of a left main coronary artery disease, and of a severe proximal left anterior 
descending stenosis (2).    
However, several lines of evidence, obtained with different approaches, demonstrate that a 
physiologic risk assessment is superior to an angiographically oriented approach in 
prognostic stratification of patients with stable ischemic heart disease. In particular, in a 
recent study, Gimelli et al (3), in order to predict patient survival rate, analyzed a group of 
676 consecutive in-patients who underwent a complete diagnostic work-up that included 
gated single photon emission computed tomography (SPECT) and coronary arteriography 
for known or suspected ischemic heart disease. Patients with acute myocardial infarction 
(MI), previous coronary artery bypass surgery, overt hyperthyroidism or who were 
undergoing dialysis treatment were excluded. 
To predict patient survival rate, the Authors utilized an angiographic semi-quantitative 
score, that takes into account the number of stenotic coronary arteries, the location of 
coronary stenoses (proximal, middle, or distal), and the degree of luminal diameter 
reduction (using a 50 and a 70% coronary stenosis threshold). As expected, this score was an 
independent predictor of event-free survival. However, the prognostic impact of this score 
disappeared once gated SPECT variables were included into the model (3).  
The notion that the prognostic impact of functional risk assessment is superior to 
angiography is not novel. In patients with defined coronary artery disease, exercise 
variables primarily relating to the functional state are known to provide an incremental 
prognostic information over coronary anatomy (4). The treadmill score also adds 
independent prognostic information to that provided by clinical data, coronary 
arteriography and left ventricular (LV) ejection fraction (5). The predictive power of clinical 
data is also strengthened by adding the results of dobutamine echocardiography (6); 
however, the power of the model was increased to a minor degree by the addition of 
coronary anatomy data. In a group of patients who underwent stress echocardiography with 
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either dipyridamole or dobutamine, and who also underwent coronary angiography within a 
year without an intervening procedure, coronary angiography parameters did not add 
significant predictive power to the model compared with stress echocardiographic variables 
(7). As to nuclear cardiology, the superiority of myocardial perfusion imaging over coronary 
angiography in risk stratification of patients with ischemic heart disease is also well known. In 
1992, Pollock et al. demonstrated that myocardial perfusion is superior to coronary 
angiography in risk stratification of ischemic heart disease patients (8); at variance with our 
study, these authors used Thallium-201 (Tl-201) and static planar imaging. In a series of 316 
medically treated patients, Iskandrian et al. (9) showed the independent and incremental 
prognostic information of exercise SPECT Tl-201 imaging even when catheterization data are 
available. All these evidences definitively underline the superiority of functional risk 
stratification over an approach based solely on angiographic coronary anatomy.  
These observations can be partly explained by the limitations of coronary angiography. First 
of all, coronary angiography has a limited sensitivity when compared to necropsy studies 
(10) and to intravascular ultrasound investigations (11). Furthermore, the identification of 
significant lesions may be confounded by coronary remodeling and by the extraluminal 
location of some plaques (12). Finally, coronary angiography does not allow to study 
coronary microcirculation, increasingly recognized as independent determinant of impaired 
blood flow, disease progression and adverse prognosis (13).  
2. The role of nuclear medicine as functional imaging 
The clinical use of radioisotopes in the evaluation of patients with ischemic heart disease is 
largely based on noninvasive methodology suitable for visualizing myocardial perfusion. 
Although contrast echocardiography and magnetic resonance imaging have been proposed 
recently for the same purpose, at present most of the noninvasive tests for assessing 
myocardial perfusion reside in nuclear cardiology. The most popular radioactive flow 
tracers are characterized by a rapid myocardial extraction followed by either a sequestration 
(for Technetium 99m labeled agents – Tc 99m) or a very slow washout (for Tl-201). These 
features make the tracer uptake proportional to blood flow in each myocardial region, even 
if, up to now, the quantitation of absolute flow is not possible with these techniques. Despite 
this limitation, myocardial perfusion can be imaged and underperfusion can be detected as 
a relative uptake defect compared with the better perfused myocardium. As “significant”  
coronary stenosis regionally impairs flow reserve, myocardial perfusion imaging has 
become a common tool for the diagnosis of coronary artery disease and coronary 
angiography the gold standard for defining its sensitivity and specificity. 
The main strength of radionuclide cardiac imaging in patients with coronary artery disease 
is to provide pathophysiologic and clinical information related to major objectives of 
assessment which include myocardial perfusion, viability and their relationship with left 
ventricular function. For these hypothesis, these data have additional value over anatomic 
information, provided by other imaging techniques, for patient management and outcome. 
3. Overview of imaging principles 
The two different approaches used to evaluate myocardial perfusion by nuclear imaging are 
SPECT and positron emission tomography (PET). SPECT gamma-emitting tracers include 
Tl-201, Tc-99m Sestamibi and Tetrofosmine. PET positron emitting tracers include O-15 
water, N-13 ammonia and rubidium-82, a generator produced readily available agent. 
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As potassium analogue, Tl-201 has high myocardium uptake and has been the most 
commonly used perfusion tracer during the past years (14). Tl-201 is distributed into the 
myocardium proportionally to the flow over a wide range of values. However, some 
limitations have recently reduced its use: the low photon energy is associated with a lower 
resolution and significant attenuation by overlying tissues; the prolonged physical half-life 
(73 hours) causes a significant radiation exposure to the patient.  
Tc-99m labeled tracers, having a shorter physical half life (6 hours) and better imaging 
capabilities, replaced Tl-201 in several indications for clinical SPECT (15). Tc-99m labeled 
tracers are readily available, the images obtained show higher spatial resolution and tissue 
attenuation is also less significant. Tc-99m Sestamibi and Tetrofosmine, the two most 
commonly used labeled tracers, distribute into the myocardium proportionally to the flow 
but their uptake is also dependent on normal mithocondrial function. After myocardial 
uptake, the retention of Tc-99 m labeled tracers in the myocardium is high so that two 
separate tracer injections are required to compare stress and resting perfusion.  
Up to now, one of the major advantages of PET over SPECT is the possibility to correct 
myocardial tissue radioactivity for attenuation of the surrounding organs so that, using 
appropriate models to describe the kinetics of the single tracer, it is possible to quantitate 
myocardial blood flow (MBF) in absolute terms (mL.g-1.min-1) (16-17). O-15 water is 
considered the gold standard for MBF quantitation because its kinetic in the heart is 
independent of myocardial metabolism (18). However, the tracer is freely diffusible and has 
a very short physical half-life (120 sec) so that images have not a high myocardial definition 
and approaches to correct for radioactivity in the vascular compartment are required for 
MBF quantitation (19).  
N-13 Ammonia is highly extracted and retained by the heart and has a relatively longer 
physical half-life than O-15 water (9.96 min) resulting in good to excellent images of the 
myocardium. However, the uptake and retention are dependent on myocardial metabolism 
(20), which may also cause regional differences in tracer accumulation (21). Rest and stress 
studies should be separated by 30 to 40 minutes to allow decay of the previously injected 
dose. There are a number of approaches for MBF quantitation with N-13 ammonia using 
one, two or three compartments models (22-24) and corrections for lower extraction at 
higher flows is used from empirical relationships obtained in experimental studies.  
Rubidium-82, is a potassium analog like Tl-201, allows good quality myocardial images and 
is available by a generator. The very short physical half-life (76 sec) allows to perform rest 
and stress studies with minimal time intervals but also introduces some challenges for the 
absolute quantitation of MBF (16).   
A typical myocardial perfusion imaging exam includes a rest-stress protocol where either a 
physical (bycicle or treadmill exercise in conjunction with SPECT) or a pharmacological 
(dipyridamole, adenosine or dobutamine in conjunction with SPECT or PET) stressor is 
applied. In general SPECT is finalized to the detection of relative regional differences in 
myocardial perfusion while PET adds the potential of measuring absolute regional MBF and 
MBF reserve. The development of ECG-gated SPECT and PET has also enabled accurate 
regional and global cardiac function measurements based on a true tomographic approach. 
The methods are relatively operator-independent and comprehensive software packages 
allow the evaluation of the extent and severity of regional LV dysfunction, in hypoperfused 
but viable myocardium, as well as of global LV ejection fraction, volumes, diastolic function 
and geometry (25-27). 
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4. Endothelial dysfunction and myocardial perfusion imaging  
Another confirmation that myocardial perfusion imaging remains one of the best predictor 
of prognosis in patients with ischemic heart disease comes from coronary microvascular 
alterations in various heart diseases.  
A specific alteration of coronary endothelial function has been found in patients with 
different diseases such as atherosclerosis (28), dilated cardiomyopathy (29) and arterial 
hypertension (30). However, the relevance of endothelial dysfunction to physiologic flow 
control has not been directly documented. Accordingly, coronary artery stenosis is still 
considered the only factor able to affect coronary blood flow regulation in a relevant fashion 
during daily life. Nevertheless, endothelium is an important factor in the integrated 
response of hyperemic flow, even to agents affecting vasomotor tone, through direct action 
on smooth muscle cells. In fact, the lack of the endothelial contribution might limit the effect 
of endothelium-independent agents on flow. 
Several studies have actually documented abnormal flow responses to dipyridamole or 
atrial pacing in the myocardium supplied by angiographically normal coronary arteries in 
patients with dilated cardiomyopathy (31) or arterial hypertension (32) and even in patients 
with single vessel disease on control coronary arteries (33). 
Thus far, the link between reduced vasodilator response and endothelial dysfunction has 
not been tested directly. However, the coincidence of both abnormalities in populations 
with various heart diseases suggests their possible association in the same patient and thus a 
potential pathophysiologic link between the two. With regard to myocardial perfusion 
imaging, the reduction in maximal flow capacity due to microvascular alterations causes a 
reduction in perfusion differences between territories perfused by angiographically normal 
and stenotic vessels during vasodilator stress, thus explaining the relative decrease in 
sensitivity of myocardial perfusion scintigraphy in the detection of single-vessel coronary 
artery disease (34). On the other side, microvascular dysfunction might produce regional flow 
abnormalities per se, thus hampering the postulated cause-effect relationship between 
epicardial stenosis and perfusion defect. 
In agreement with this concept, Zeiher et al (35) demonstrated that coronary microvascular 
endothelial dysfunction was associated with a high incidence of reversible perfusion defects at 
stress myocardial perfusion imaging despite the absence of coronary stenosis. According to the 
traditional criteria, the abnormal scan results of these patients are considered to be “false 
positive”. In contrast, this feature might represent an actual stenosis-independent abnormality 
in blood flow distribution rather than the effect of technical artifacts such as attenuation or 
partial-volume effect. This concept seems of great relevance, as monitoring of microvascular 
function can also be used for assessing the efficacy of therapy. Gould (36) demonstrated that 
aggressive cholesterol lowering is able to reduce reversible perfusion defects induced by 
dipyridamole. Guethlin et al (37) showed that statin therapy improves myocardial blood flow 
response to adenosine independently of stenosis severity in the related vessel. The most 
striking feature of these findings is that the interventions thought to improve endothelial 
function actually improved the flow response to endothelial independent stimuli, underlining 
the relevance of the endothelium in the integrated tuning of vasomotor tone. 
5. Functional risk assessment vs. noninvasive coronary angiography 
The prognostic value of coronary artery calcium (CAC) has been consistently demonstrated 
in large series of patients (39-41). Current evidence also suggests that the use of CAC is 
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independently predictive of outcome over and above traditional cardiac risk factors. As to 
functional risk assessment, CAC scores are predictive of a higher likelihood of ischemia on 
PET myocardial perfusion imaging (42). More importantly, patients with and without 
ischemia on PET perfusion imaging exhibit a stepwise increase in their risk of cardiac events 
with increasing calcium scores. These findings suggest that imaging approaches that 
combine quantitative information on the anatomic burden of ischemic heart disease with its 
physiological consequences offer improved risk stratification over conventional approaches 
that use myocardial perfusion alone. However, an independent and incremental prognostic 
value of CAC over clinical, electrocardiographic, laboratory, echocardiographic and 
angiographic variables has not been demonstrated yet. 
A similar consideration applies to computed tomography (CT) of the coronary arteries. 
Although the presence of obstructive coronary lesions at 64-slice CT angiography was a 
predictor of an adverse outcome (death, nonfatal myocardial infarction, unstable angina, 
and coronary revascularization) as compared to the patients with normal coronary arteries 
(43), an independent and incremental prognostic value of CT angiography over clinical, 
electrocardiographic, echocardiographic and scintigraphic variables has not been 
demonstrated. Up to now, two studies have been designed to test the impact of a combined 
anatomic and functional non-invasive imaging for detection and characterization of 
ISCHEMIC HEART DISEASE: the EVINCI study in Europe and the SPARC trial in the 
United States of America. While we are waiting for the results of these two trials, patients 
outcome in stable ischemic heart disease should be estimated using the evidences so far 
collected. 
6. Myocardial perfusion imaging and revascularization 
No differences in the composite of death, acute myocardial infarction and stroke was found 
between patients with stable ischemic heart disease, objective evidence of ischemia and 
significant coronary stenoses randomized to optimal medical therapy with or without 
percutaneous coronary intervention in the COURAGE trial (44). The relationship between 
extent of myocardial ischemia at gated SPECT and coronary revascularization has been 
explored in a subset of patients enrolled in a nuclear substudy of the COURAGE trial (45). In 
these patients, the addition of percutaneous coronary intervention to optimal medical 
therapy resulted in more effective reduction of ischemia than optimal medical therapy 
alone. This greater reduction in ischemic burden was associated with improvements in 
angina class and less reliance on nitrate therapy for symptom relief. Moreover, patients with 
moderate to severe ischemia randomized to percutaneous coronary intervention plus 
optimal medical therapy more commonly experienced a significant reduction in ischemia at 
follow-up compared with those receiving optimal medical therapy (78% versus 52%). Thus, 
the results of the nuclear substudy suggest that gated SPECT could be utilized for the 
identification of patients who will benefit more from coronary revascularization.  
7. The proper diagnostic work-up 
In patients with stable ischemic heart disease, myocardial perfusion imaging may be 
sometimes regarded as an unnecessary, or even redundant investigation. The study of 
Gimelli and Colleagues shows that myocardial perfusion abnormalities at rest and after 
stress are still the best predictors of cardiac event-free survival, even when compared with 
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an extensive diagnostic work-up. Specifically, when gated SPECT data were added to the 
clinical, laboratory, electrocardiographic and echocardiographic variables, the prognostic 
stratification significantly improved; however, when coronary angiography was added to 
gated SPECT, prognostic stratification did not further improve (Figure 1, top panel). On the 
other hand, if the information provided by gated SPECT was made available after clinical, 
laboratory, electrocardiographic, echocardiographic and angiographic variables, the 
prognostic stratification still improved significantly (Figure 1, lower panel). Thus, gated 
 
 
Modified from Gimelli et al, J Nucl Med 2009;50:546-53 
Fig. 1. Incremental prognostic value during the diagnostic work-up.  In the upper panel, the 
information provided by stress/ rest gated SPECT is available after clinical examination, 
laboratory tests, electrocardiography and echocardiography but before coronary 
angiography. In the lower panel, the information provided by gated SPECT is available after 
coronary angiography.  
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SPECT adds a prognostic information that is greater than that provided by coronary 
angiography. This observation suggests that the indications for myocardial perfusion 
imaging in risk stratification of patients with known or suspected ischemic heart disease 
should be broadened. 
In current clinical practice, a functional risk assessment may conflict with a health care 
delivery policy oriented towards cost saving and direct reperfusion. In this respect, a recent 
survey of the European Society of Cardiology has shown that non-invasive functional tests 
are under-utilized, with wide variability between different countries (46), so that several 
patients without significant ischemic heart disease directly undergo invasive coronary 
angiography. On the other hand, coronary lesions detected by coronary angiography are 
often revascularized even without the evidence that either myocardial blood supply or 
mechanical function is altered (47). This “anatomically oriented”  invasive approach may 
negatively affect patient management, with consequent suboptimal medical treatment, 
inappropriate revascularizations, additional risks and increased health costs.  
8. Conclusions 
Several lines of evidence, collected with different approaches, demonstrate that a 
physiologic risk assessment is superior to an angiographically oriented approach in 
prognostic stratification of patients with stable ischemic heart disease. On these basis, 
stress/ rest myocardial perfusion abnormalities should be known – whenever possible - 
before coronary angiography in order to guide decision making, provided that 
appropriateness and patient’s risk/ benefits ratio are correctly considered. 
9. References 
[1] Emond M, Mock MB, Davis KB, Fisher LD, Holmes DR Jr, Chaitman BR, et al. Long-term 
survival of medically treated patients in the Coronary Artery Surgery Study (CASS) 
Registry. Circulation 1994;90:2645-57. 
[2] Mark DB, Nelson CL, Califf RM, Harrell FE Jr, Lee KL, Jones RH, et al. Continuing 
evolution of therapy for coronary artery disease. Initial results from the era of 
coronary angioplasty. Circulation. 1994;89:2015-25. 
[3] Gimelli A, Rossi G, Landi P, Marzullo P, Iervasi G, L'abbate A, et al. Stress/ Rest 
Myocardial Perfusion Abnormalities by Gated SPECT: Still the Best Predictor of 
Cardiac Events in Stable Ischemic Heart Disease. J Nucl Med 2009;50:546-53.  
[4] Weiner DA, Ryan TJ, McCabe CH, Chaitman BR, Sheffield LT, Ferguson JC, et al. 
Prognostic importance of a clinical profile and exercise test in medically treated 
patients with coronary artery disease. J Am Coll Cardiol. 1984;3:772-9. 
[5] Mark DB, Hlatky MA, Harrell FE Jr, Lee KL, Califf RM, Pryor DB. Exercise treadmill 
score for predicting prognosis in coronary artery disease. Ann Intern Med. 
1987;106:793-800. 
[6] Marwick TH, Case C, Sawada S, Rimmerman C, Brenneman P, Kovacs R, et al. 
Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol. 
2001;37:754-60. 
[7] Sicari R, Pasanisi E, MD, Venneri L, MD, Landi P, BSC, Cortigiani C, MD, Picano E, MD, 
PHD, on behalf of the Echo Persantine International Cooperative (EPIC) and Echo 
Dobutamine International Cooperative (EDIC) Study Groups. Stress Echo Results 
www.intechopen.com
Coronary Angiography 
 – Advances in Noninvasive Imaging Approach for Evaluation of Coronary Artery Disease 
 
222 
Predict Mortality: A Large-Scale Multicenter Prospective International Study. J Am 
Coll Cardiol 2003;41:589–95. 
[8] Pollock SG, Abbott RD, Boucher CA, Beller GA, Kaul S. Independent and incremental 
prognostic value of tests performed in hierarchical order to evaluate patients with 
suspected coronary artery disease: validation of models based on these tests. 
Circulation. 1992;85:237–48. 
[9] Iskandrian AS, Chae SC, Heo J, Stanberry CD, Wasserleben V, Cave V. Independent and 
incremental prognostic value of exercise single-photon emission computed 
tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll 
Cardiol. 1993;22:665–70. 
[10] Michalodimitrakis M, Mavroforou A, Giannoukas AD. Lessons learnt from the 
autopsies of 445 cases of sudden cardiac death in adults. Coron Artery Dis. 2005;16: 
385-89. 
[11] Nissen SE. Pathobiology, not angiography, should guide management in acute 
coronary syndrome/ non-ST-segment elevation myocardial infarction: the non-
interventionist's perspective. J Am Coll Cardiol. 2003; 41:103S-112S. 
[12] Sipahi I, Tuzcu EM, Schoenhagen P, Nicholls SJ, Chen MS, Crowe T, et al. Paradoxical 
increase in lumen size during progression of coronary atherosclerosis: 
Observations from the REVERSAL trial. Atherosclerosis. 2006 Jan 19; 189:229-35. 
[13] Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L, et al. 
Prognostic role of myocardial blood flow impairment in idiopathic left ventricular 
dysfunction. Circulation. 2002;105:186-93. 
[14] Verani MS. Thallium-201 and technetium-99m perfusion agents: where we are in 1992. 
In: Zaret BL, Beller GA, eds. Nuclear Cardiology: State of the Art and Future 
Directions. St Louis, Mo: Mosby; 1993: 216-24. 
[15] Maddahi J, Kiat H, Friedman JD, et al. Technetium-99m-sestamibi myocardial 
perfusion imaging for evaluation of coronary artery disease. In: Zaret BL, Beller 
GA, eds. Nuclear Cardiology: State of the Art and Future Directions. St Louis, Mo: 
Mosby; 1993:191-200. 
[16] Bergmann SR. Quantification of myocardial perfusion with positron emission 
tomography. In: Bergmann SR, Sobel BE, editors. Positron emission tomography of 
the heart. Mount Kisco (NY): Futura Publishing; 1992. p. 97-127. 
[17] Phelps ME. PET-Molecular imaging and its biological applications. Springer-Verlag, 
New York, 2004 
[18] Bergmann SR, Herrero P, Markham J, Weinheimer CJ, Walsh MN. Noninvasive 
quantitation of myocardial blood flow in human subjects with oxygen-15-labeled 
water and positron emission tomography. J Am Coll Cardiol 1989;14:639-52. 
[19] Araujo LI, Lammertsma AA, Rhodes CG, et al. Noninvasive quantification of regional 
myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon 
dioxide inhalation and positron emission tomography. Circulation 1991;83:875-85. 
[20] Krivokapich J, Huang S-C, Phelps ME, MacDonald NS, Shine KI. Dependence of 
13NH3 myocardial extraction and clearance on flow and metabolism. Am J Physiol 
Heart Circ Physiol 1982;242:H536-42. 
[21] de Jong RM, Blanksma PK, Willemsen AT, et al. Posterolateral defect of the normal 
human heart investigated with nitrogen-13-ammonia and dynamic PET. J Nucl 
Med 1995;36:581-5. 
www.intechopen.com
Physiologic Risk Assessment in Stable Ischemic 
Heart Disease – Functional Evaluation Versus Coronary Anatomy 
 
223 
[22] Bellina RC, Parodi O, Camici P, et al. Simultaneous in vitro and in vivo validation of 
nitrogen-13 ammonia for the assessment of regional myocardial blood flow. J Nucl 
Med. 1990;31:1335–1343.  
[23] Krivokapich J, Smith GT, Huang SC, et al. 13N ammonia myocardial imaging at rest 
and with exercise in normal volunteers. Quantification of absolute myocardial 
perfusion with dynamic positron emission tomography. Circulation 1989;80:1328-
37.  
[24] Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. 
Noninvasive quantification of regional blood flow in the human heart using N-13 
ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 
1990;15:1032-42. 
[25] Germano G., Kiat H., Kavanagh P.B. et al. Automatic quantification of ejection fraction 
from gated myocardial perfusion SPECT. J Nucl Med 1995; 36: 2138-2147. 
[26] Germano G, Erel J, Lewin H, Kavanagh PB, Berman DS. Automatic quantitation of 
regional myocardial wall motion and thickening from gated technetium-99m 
sestamibi myocardial perfusion singlephoton emission computed tomography. J 
Am Coll Cardiol 1997;30:1360-7. 
[27] Bateman TM, Heller GV, McGhie AI, et al. Diagnostic accuracy of rest/ stress ECG-
gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m 
sestamibi SPECT. J Nucl Cardiol 2006;13:24-33. 
[28] Chilian WM, Dellsperger KC, Layne SM, Eastham CL, Armstrong MA, Marcus ML, et 
al. Effect of atherosclerosis on the coronary microcirculation. Am J Physiol 
1990;258: H529-H539. 
[29] Treasure CB, Vita JA, Cox DA, Fish RD, Gordon JB, Mudge GH, et al. Endothelium-
dependent dilation of the coronary microvasculature is impaired in dilated 
cardiomyopathy. Circulation 1990;81:772-9. 
[30] Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent 
relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7. 
[31] Neglia D, Parodi O, Gallopin M, Sambuceti G, Giorgetti A, Pratali L, et al. Myocardial 
blood flow response to pacing tachycardia and to dipyridamole infusion in patients 
with dilated cardiomyopathy without overt heart failure. A quantitative 
assessment by positron emission tomography. Circulation 1995; 92:796-804. 
[32] Parodi O, Neglia D, Palombo C, Sambuceti G, Giorgetti A, Marabotti C, et al. 
Comparative effects of enalapril and verapamil on myocardial blood flow in 
systemic hypertension. Circulation 1997;96:864-73. 
[33] Sambuceti G, Marzullo P, Giorgetti A, Neglia D, Marzilli M, Salvadori P, et al. Global 
alteration in perfusion response to increasing oxygen consumption in patients with 
single vessel coronary artery disease. Circulation 1994;90:1696-705. 
[34] Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of 
patients with coronary artery disease. Circulation 2000;101:1465-78. 
[35] Zeiher AM, Krause T, Schachinger V, Minners J, Moser E. Impaired endothelium-
dependent vasodilation of coronary resistance vessels is associated with exercise-
induced myocardial ischemia. Circulation 1995;91:2345-52. 
[36] Gould KL. Myocardial perfusion after cholesterol lowering. Atheroscler Thromb 
1996;3:59-61. 
www.intechopen.com
Coronary Angiography 
 – Advances in Noninvasive Imaging Approach for Evaluation of Coronary Artery Disease 
 
224 
[37] Guethlin M, Kasel AM, Coppenrath K, Ziegler S, Delius W, Schwaiger M. Delayed 
response of myocardial flow reserve to lipid-lowering therapy with fluvastatin. 
Circulation 1999;99: 475-81. 
[38] Sambuceti G, Marzilli M, Marraccini P, Schneider-Eicke J, Gliozheni E, Parodi O, et al. 
Coronary vasoconstriction during myocardial ischemia induced by rises in 
metabolic demand in patients with coronary artery disease. Circulation 
1997;95:2652-9. 
[39] Budoff MJ, Shaw LJ, Liu ST, Weinstein SR, Mosler TP, Tseng PH, et al. Long-term 
prognosis associated with coronary calcification: observations from a registry of 
25,253 patients. J Am Coll Cardiol. 2007;49:1860-70. 
[40] Taylor AJ, Bindeman J, Feuerstein I, Cao F, Brazaitis M, O’ Malley PG. Coronary 
calcium independently predicts incident premature coronary heart disease over 
measured cardiovascular risk factors: mean three-year outcomes in the Prospective 
Army Coronary Calcium (PACC) project. J Am Coll Cardiol 2005;46: 807–14. 
[41] Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium 
score combined with Framingham score for risk prediction in asymptomatic 
individuals. JAMA 2004;291:210 –5. 
[42] Schenker MP, Dorbala S, Cho Tek Hong , et al. Interrelation of coronary calification, 
myocardial ischemia and outcomes in patients with intermediate likelihood of 
coronary artery disease: A combined positron emission tomography/ computed 
tomography study. Circulation. 2008;117:1693-1700. 
[43] Gaemperli O, Valenta I, Schepis T, Husmann L, Scheffel H, Desbiolles L, et al. 
Coronary 64-slice CT angiography predicts outcome in patients with known or 
suspected coronary artery disease. Eur Radiol 2008;18:1162-73. 
[44] Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal 
medical therapy with or without PCI for stable coronary disease. N Engl J Med. 
2007;356:1503–16. 
[45] Shaw LJ, Barman DS, Maron DJ et al. Optimal Medical Therapy With or Without 
Percutaneous Coronary Intervention to Reduce Ischemic Burden Results From the 
Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation 
(COURAGE) Trial Nuclear Substudy. Circulation. 2008;117:1283-91. 
[46] Breeman A, Hordijk-Trion M, Lenzen M, Hoeks S, Ottervanger JP, Bertrand ME et al. 
Euro Heart Survey on Coronary Revascularization. Treatment decisions in stable 
coronary artery disease: insights from the Euro Heart Survey on Coronary 
Revascularization. J Thorac Cardiovasc Surg 2006;132:1001-9. 
[47] Daly CA, Clemens F, Sendon JL, Tavazzi L, Boersma E, Danchin N, et al. Euro Heart 
Survey Investigators. The clinical characteristics and investigations planned in 
patients with stable angina presenting to cardiologists in Europe: from the Euro 
Heart Survey of Stable Angina. Eur Heart J 2005; 26:996-1010. 
www.intechopen.com
Coronary Angiography - Advances in Noninvasive Imaging
Approach for Evaluation of Coronary Artery Disease
Edited by Prof. Baskot Branislav
ISBN 978-953-307-675-1
Hard cover, 414 pages
Publisher InTech
Published online 15, September, 2011
Published in print edition September, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
In the intervening 10 years tremendous advances in the field of cardiac computed tomography have occurred.
We now can legitimately claim that computed tomography angiography (CTA) of the coronary arteries is
available. In the evaluation of patients with suspected coronary artery disease (CAD), many guidelines today
consider CTA an alternative to stress testing. The use of CTA in primary prevention patients is more
controversial in considering diagnostic test interpretation in populations with a low prevalence to disease.
However the nuclear technique most frequently used by cardiologists is myocardial perfusion imaging (MPI).
The combination of a nuclear camera with CTA allows for the attainment of coronary anatomic, cardiac
function and MPI from one piece of equipment. PET/SPECT cameras can now assess perfusion, function, and
metabolism. Assessing cardiac viability is now fairly routine with these enhancements to cardiac imaging. This
issue is full of important information that every cardiologist needs to now.
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